golimumab   

GtoPdb Ligand ID: 6776

Synonyms: CNTO-148 | CNTO148 | Simponi®
golimumab is an approved drug (FDA (2009), EMA (2009))
Compound class: Antibody
Comment: TNFα inhibitor.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: golimumab

Immunopharmacology Disease
Disease X-Refs Comment References
Psoriasis Disease Ontology: DOID:8893
An anti-TNFα therapy approved for psoriasis.
Rheumatoid arthritis Disease Ontology: DOID:7148
OMIM: 180300
An anti-TNFα therapy approved for RA.
Ulcerative colitis Disease Ontology: DOID:8577
OMIM: 266600
Orphanet: ORPHA771
An anti-TNFα therapy approved for CD.
Ankylosing spondylitis Disease Ontology: DOID:7147
An anti-TNFα therapy approved for ankylosing spondylitis.